Institutional investors purchased a net $643.2 thousand shares of NEO during the quarter ended March 2017, and now own 58.61% of the total float, a percentage that is typical for companies in the Medical/Nursing Services industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
JANUS CAPITAL MANAGEMENT LLC Bought 1.7 Million shares of Neogenomics Inc
GABELLI FUNDS LLC Bought 353.8 Thousand shares of Neogenomics Inc
IRONBRIDGE CAPITAL MANAGEMENT LP Bought 314.5 Thousand shares of Neogenomics Inc